limonin has been researched along with Cardiometabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jan-O, B; Maneesai, P; Pakdeechote, P; Phuthong, S; Poasakate, A; Rattanakanokchai, S; Tong-Un, T | 1 |
| Bassossy, HME; Fahmy, A; Hassan, NA; Mahmoud, MF | 1 |
2 other study(ies) available for limonin and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Limonin mitigates cardiometabolic complications in rats with metabolic syndrome through regulation of the IRS-1/GLUT4 signalling pathway.
Topics: Animals; Blood Glucose; Cardiovascular Diseases; Diet, High-Fat; Glucose Transporter Type 4; Hypertrophy; Insulin; Insulin Receptor Substrate Proteins; Limonins; Metabolic Syndrome; Rats | 2023 |
Limonin alleviates macro- and micro-vascular complications of metabolic syndrome in rats: A comparative study with azelnidipine.
Topics: Animals; Aorta, Thoracic; Azetidinecarboxylic Acid; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Fructose; Glycation End Products, Advanced; Hypertension; Insulin Resistance; Limonins; Male; Metabolic Syndrome; Rats | 2018 |